Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America.

The spinal cord stimulation system comes from Greatbatch’s subsidiary, QiG Group. The company also applied for pre-market approval last month.

This bid shows “development of complete medical device systems in order to raise the growth and profitability profile” of the company, according to a regulatory filing.